Dexcom Inc
XETRA:DC4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dexcom Inc
XETRA:DC4
|
US |
|
F
|
Footshop as
PSE:FTSHP
|
CZ |
|
Nippn Corp
TSE:2001
|
JP |
|
F
|
Fortune Brands Innovations Inc
SWB:2FB
|
US |
|
National Vision Holdings Inc
NASDAQ:EYE
|
US |
|
G
|
Gazprom Neft' PAO
LSE:GAZ
|
RU |
|
I
|
International Consolidated Airlines Group SA
OTC:ICAGY
|
UK |
|
V
|
Vodafone Group PLC
BMV:VODN
|
UK |
|
Y
|
Yara International ASA
XBER:IU2
|
NO |
|
S
|
Stolt-Nielsen Ltd
OTC:SOIEF
|
UK |
|
F5 Inc
NASDAQ:FFIV
|
US |
|
Bank of Communications Co Ltd
HKEX:3328
|
CN |
Wall St Price Targets
DC4 Price Targets Summary
Dexcom Inc
According to Wall Street analysts, the average 1-year price target for DC4 is 73.3 EUR with a low forecast of 57.33 EUR and a high forecast of 99.63 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DC4's stock price target?
Price Target
73.3
EUR
According to Wall Street analysts, the average 1-year price target for DC4 is 73.3 EUR with a low forecast of 57.33 EUR and a high forecast of 99.63 EUR.
What is the Revenue forecast for Dexcom Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 8 years is 10%.
What is the Operating Income forecast for Dexcom Inc?
Projected CAGR
16%
The compound annual growth rate for Operating Income over the next 8 years is 16%.
What is the Net Income forecast for Dexcom Inc?
Projected CAGR
19%
The compound annual growth rate for Net Income over the next 5 years is 19%.
